HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hidenori Fukuoka Selected Research

Antigens

12/2021Mechanistic insights into immune checkpoint inhibitor-related hypophysitis: a form of paraneoplastic syndrome.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Hidenori Fukuoka Research Topics

Disease

30Neoplasms (Cancer)
04/2024 - 01/2011
12Hypophysitis
04/2024 - 10/2015
12Pituitary Neoplasms (Pituitary Adenoma)
02/2024 - 10/2011
10Acromegaly
11/2023 - 01/2008
8Hypothyroidism
01/2023 - 01/2011
7Pituitary ACTH Hypersecretion
06/2022 - 12/2011
6ACTH-Secreting Pituitary Adenoma
02/2024 - 04/2015
6Adenoma (Adenomas)
02/2024 - 01/2011
6Pheochromocytoma
01/2024 - 01/2017
5Cushing Syndrome
02/2024 - 01/2014
5Paraganglioma (Paragangliomas)
01/2024 - 01/2014
5Type 1 Diabetes Mellitus (Autoimmune Diabetes)
01/2024 - 01/2014
5Prolactinoma (Prolactinomas)
12/2023 - 01/2011
5Adrenocortical Adenoma (Disease, Conn's)
01/2022 - 01/2017
5Autoimmune Hypophysitis
11/2019 - 01/2014
5Non-alcoholic Fatty Liver Disease
01/2018 - 03/2007
4Paraneoplastic Syndromes (Paraneoplastic Syndrome)
04/2024 - 10/2018
4Adrenal Insufficiency (Adrenal Gland Hypofunction)
01/2024 - 01/2018
4Insulin Resistance
02/2023 - 03/2007
4Carcinoma (Carcinomatosis)
01/2023 - 10/2018
4Carcinogenesis
01/2015 - 08/2012
3Thymoma (Thymic Carcinoma)
01/2024 - 01/2020
3COVID-19
03/2023 - 11/2022
3Autoimmune Diseases (Autoimmune Disease)
03/2021 - 01/2014
2Disease Progression
04/2024 - 02/2019
2Stomach Neoplasms (Stomach Cancer)
04/2024 - 01/2024
2Cysts
04/2024 - 01/2016
2Neoplasm Metastasis (Metastasis)
04/2024 - 01/2023
2Thyroiditis
01/2024 - 04/2021
2Hypopituitarism (Sheehan's Syndrome)
11/2022 - 02/2014
2Myxoma (Myxomas)
11/2020 - 01/2020
2Growth Hormone-Secreting Pituitary Adenoma
10/2019 - 10/2018
2Malnutrition (Nutritional Deficiencies)
01/2018 - 09/2013
2Inflammation (Inflammations)
10/2016 - 07/2012
2Obesity
01/2016 - 01/2013
2Multiple Endocrine Neoplasia Type 1
01/2014 - 01/2014
2Carney Complex
01/2014 - 01/2014
1Lymphatic Metastasis
04/2024
1Thyroid Neoplasms (Thyroid Cancer)
04/2024
1Hypokalemia
02/2024
1Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
01/2024
1Diabetic Ketoacidosis (Ketoacidosis, Diabetic)
01/2024
1Hyperprolactinemia
12/2023

Drug/Important Bio-Agent (IBA)

19Growth Hormone (Somatotropin)IBA
04/2024 - 03/2007
15Adrenocorticotropic Hormone (ACTH)FDA Link
02/2024 - 12/2011
15Insulin-Like Growth Factor I (IGF-1)IBA
11/2023 - 01/2008
11ProlactinIBA
04/2024 - 01/2011
10Hydrocortisone (Cortisol)FDA LinkGeneric
02/2024 - 01/2014
9Immune Checkpoint InhibitorsIBA
04/2024 - 01/2018
9Thyrotropin (Thyroid-Stimulating Hormone)FDA Link
04/2024 - 01/2011
8Glucose (Dextrose)FDA LinkGeneric
02/2023 - 01/2008
6Insulin (Novolin)FDA Link
02/2023 - 06/2010
6Proteins (Proteins, Gene)FDA Link
03/2021 - 01/2011
5LigandsIBA
11/2023 - 01/2011
5GlucocorticoidsIBA
03/2023 - 02/2019
5Pro-Opiomelanocortin (Proopiomelanocortin)IBA
01/2023 - 12/2011
4Hormones (Hormone)IBA
04/2024 - 01/2011
4Dopamine Agonists (Dopamine Agonist)IBA
12/2023 - 01/2011
4AntibodiesIBA
01/2023 - 09/2014
4Isolated ACTH DeficiencyIBA
01/2023 - 02/2014
4Tyrosine Kinase InhibitorsIBA
02/2017 - 10/2011
4Reactive Oxygen Species (Oxygen Radicals)IBA
08/2012 - 03/2007
3Capecitabine (Xeloda)FDA Link
04/2024 - 01/2022
3MetyraponeFDA Link
02/2024 - 06/2021
3Thyroid HormonesIBA
01/2024 - 03/2017
3Transcription Factors (Transcription Factor)IBA
12/2023 - 01/2020
3Octreotide (Sandostatin)FDA LinkGeneric
11/2023 - 01/2013
3CatecholaminesIBA
11/2023 - 01/2017
3Temozolomide (Temodar)FDA LinkGeneric
04/2022 - 01/2021
3Somatostatin (Somatotropin Release-Inhibiting Factor)IBA
01/2022 - 01/2013
3ErbB Receptors (EGF Receptor)IBA
02/2017 - 01/2011
2NivolumabIBA
04/2024 - 01/2024
2Thyroxine (Levothyroxine)FDA LinkGeneric
01/2024 - 08/2015
2Triiodothyronine (Liothyronine)FDA LinkGeneric
01/2024 - 08/2015
2Somatostatin Receptors (Somatostatin Receptor)IBA
11/2023 - 10/2018
2Therapeutic UsesIBA
11/2023 - 04/2022
2Dexamethasone (Maxidex)FDA LinkGeneric
03/2023 - 06/2021
2Fumarate Hydratase (Fumarase)IBA
11/2020 - 01/2020
2CorticosteroneIBA
02/2017 - 12/2011
2Gefitinib (Iressa)FDA Link
02/2017 - 12/2011
2Insulin-Like PeptidesIBA
01/2016 - 06/2012
2Immunoglobulin G (IgG)IBA
10/2015 - 02/2014
2Lapatinib (GW572016)FDA Link
01/2015 - 01/2011
2Succinic Acid (Succinate)IBA
01/2014 - 01/2014
2Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
01/2014 - 01/2014
2Oxidoreductases (Dehydrogenase)IBA
01/2014 - 01/2014
2AntioxidantsIBA
03/2011 - 06/2010
1Oxaliplatin (Eloxatin)FDA LinkGeneric
04/2024
1ThyroglobulinFDA Link
04/2024
1Galectin 3 (LGALS3)IBA
04/2024
1alpha-Methyltyrosine (Metirosine)FDA Link
01/2024
1Doxazosin (Cardura)FDA LinkGeneric
01/2024
1Phenylethanolamine N-MethyltransferaseIBA
11/2023

Therapy/Procedure

18Therapeutics
04/2024 - 01/2011
4Radiotherapy
12/2023 - 12/2015
3Immunotherapy
02/2024 - 01/2018
2Adrenalectomy
04/2024 - 09/2020
2Drug Therapy (Chemotherapy)
01/2024 - 01/2018
2Critical Care (Surgical Intensive Care)
03/2023 - 11/2022
1Gastrectomy
01/2024